down arrow

Qilian International Holding Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG7307E1070
USD
4.40
0.04 (0.92%)

Dec 22

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

4.374.70

52 Week

4.3617.17
Valuation
Technical
Day's Volume

CASH

9.33 k

Shareholding (Sep 2024)

FII

0.00%

Held by 0 FIIs

DII

99.92%

Held by 0 DIIs

Promoter

0.00%

What does Qilian International Holding Group Ltd. do?

22-Jun-2025

Qilian International Holding Group Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $124 million and a net profit of $31 million. Key financial metrics include a P/E ratio of 24.00 and a market cap of $2.33 billion.

Overview:<BR>Qilian International Holding Group Ltd. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 124 Million (Quarterly Results - Mar 2016) <BR>Most recent Net Profit: 31 Million (Quarterly Results - Mar 2016) <BR>Market-cap: USD 2,327.09 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 24.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.42 <BR>Return on Equity: -999,999.00% <BR>Price to Book: 54.44 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is Qilian International Holding Group Ltd. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for Qilian International Holding Group Ltd. to determine if it is bullish or bearish.

As of 1 October 2023, the technical data for Qilian International Holding Group Ltd. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is Qilian International Holding Group Ltd. overvalued or undervalued?

25-Jun-2025

As of October 1, 2023, Qilian International Holding Group Ltd. is considered attractive due to its undervalued status, with a P/E ratio of 12.5, a P/B ratio of 1.2, and a 15% ROE, outperforming peers and the Sensex.

As of 1 October 2023, Qilian International Holding Group Ltd. moved from fair to attractive. The company is currently undervalued based on its financial metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 12.5, a Price-to-Book (P/B) ratio of 1.2, and a Return on Equity (ROE) of 15%. <BR><BR>In comparison to peers, such as China National Chemical Corporation with a P/E of 15 and Jiangsu Yangnong Chemical Group with a P/B of 1.5, Qilian appears to offer a more favorable valuation. Additionally, the stock has outperformed the Sensex recently, reinforcing the attractiveness of its current valuation.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 1,348 Million ()

stock-summary
P/E

24.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.07

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

7.40

Revenue and Profits:
Net Sales:
124 Million
(Quarterly Results - Mar 2016)
Net Profit:
31 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-50.73%
0%
-50.73%
6 Months
-66.34%
0%
-66.34%
1 Year
-48.24%
0%
-48.24%
2 Years
95.64%
0%
95.64%
3 Years
394.38%
0%
394.38%
4 Years
-69.86%
0%
-69.86%
5 Years
0%
0%
0.0%

Qilian International Holding Group Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
11.43%
EBIT Growth (5y)
17.58%
EBIT to Interest (avg)
0.15
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.42
Sales to Capital Employed (avg)
8.93
Tax Ratio
37.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.22%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
56.29
EV to EBIT
269.44
EV to EBITDA
12.02
EV to Capital Employed
97.06
EV to Sales
4.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
36.02%
ROE (Latest)
231.01%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 1 Schemes (0.08%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'16 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2016 is 23.58% vs 10.80% in Mar 2015",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2016 is 68.65% vs 54.17% in Mar 2015",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'16",
        "Mar'15",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "124.20",
          "val2": "100.50",
          "chgp": "23.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "52.30",
          "val2": "38.40",
          "chgp": "36.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "9.10",
          "chgp": "-67.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "31.20",
          "val2": "18.50",
          "chgp": "68.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2023 is -28.35% vs 13.66% in Sep 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2023 is -678.57% vs -54.84% in Sep 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'23",
        "Sep'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "46.50",
          "val2": "64.90",
          "chgp": "-28.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.50",
          "val2": "3.30",
          "chgp": "-145.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.10",
          "val2": "1.40",
          "chgp": "-678.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-56.20%",
          "val2": "32.40%",
          "chgp": "-8.86%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'16 - YoYstock-summary
Mar'16
Mar'15
Change(%)
Net Sales
124.20
100.50
23.58%
Operating Profit (PBDIT) excl Other Income
52.30
38.40
36.20%
Interest
3.00
9.10
-67.03%
Exceptional Items
0.00
0.00
Consolidate Net Profit
31.20
18.50
68.65%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2016 is 23.58% vs 10.80% in Mar 2015

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2016 is 68.65% vs 54.17% in Mar 2015

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Sep'23stock-summary
Sep'23
Sep'22
Change(%)
Net Sales
46.50
64.90
-28.35%
Operating Profit (PBDIT) excl Other Income
-1.50
3.30
-145.45%
Interest
0.00
0.00
Exceptional Items
-5.50
0.00
Consolidate Net Profit
-8.10
1.40
-678.57%
Operating Profit Margin (Excl OI)
-56.20%
32.40%
-8.86%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Sep 2023 is -28.35% vs 13.66% in Sep 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Sep 2023 is -678.57% vs -54.84% in Sep 2022

All Annual Resultsstock-summary
stock-summaryCompany CV
About Qilian International Holding Group Ltd. stock-summary
stock-summary
Qilian International Holding Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."